ATHX stock pitch - 2019-12-24

Added to YB: 2019-12-24

Pitch date: 2019-12-24

Athersys, Inc.

current return

Author Info

No bio for this author

Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium

Company Info

Athersys, Inc., a clinical-stage biotechnology company, develops therapies in the regenerative medicine area.

Market Cap

$61.00

Pitch Price

$31.50

Price Target

N/A

Dividend

N/A

EV/EBITDA

N/A

P/E

0.00

EV/Sales

N/A

Sector

Biotechnology

A summary for this pitch has not been created yet.